H. Pylori Pack

Helicobacter pylori is a bacterial infection of the stomach lining that affects nearly half the world's population and is a leading cause of chronic gastritis, peptic ulcers, and increased risk of gastric cancer. Left unaddressed, H. pylori disrupts the gut's protective mucosal barrier, impairs digestion, and contributes to systemic inflammation that can affect overall health. Berberine and Triphala have demonstrated direct antimicrobial activity against H. pylori strains, while NAC works to break down the biofilm that shields the bacteria from immune defenses. The 10B Probiotic helps restore beneficial gut flora disrupted by the infection, and Ginger, Quercetin, Zinc, and Turmeric collectively reduce gastric inflammation, support mucosal healing, and strengthen the gut's natural defenses against bacterial colonization.

- Supports a healthy stomach lining and mucosal integrity to promote comfortable upper GI function and efficient nutrient absorption. - Helps maintain balanced gastric acid and a clean gastric environment for everyday digestive comfort. - Fosters a harmonious upper GI microbiome and mucosal immune balance for a resilient gastric ecosystem. - Promotes healthy motility and regularity for smooth digestive transit and upper GI comfort. - Encourages a balanced inflammatory response in the stomach and upper GI to support ongoing comfort and tissue health.

- Efficacy and safety of triple therapy containing berberine, amoxicillin, and vonoprazan for Helicobacter pylori initial treatment: A randomized controlled trial — https://pubmed.ncbi.nlm.nih.gov/37469024/ - An Additive Effect of Oral N-Acetyl Cysteine on Eradication of Helicobacter pylori — https://onlinelibrary.wiley.com/doi/10.1155/2015/540271 - Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: A prospective randomized placebo-controlled double-blind study — https://pubmed.ncbi.nlm.nih.gov/17669103/ - The Gastro-protective Effect of Ginger (Zingiber officinale Roscoe) in Helicobacter pylori Positive Functional Dyspepsia — https://pmc.ncbi.nlm.nih.gov/articles/PMC6664109/ - Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial — https://pubmed.ncbi.nlm.nih.gov/28407007/ - A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: Something to learn from failure? — https://pubmed.ncbi.nlm.nih.gov/17493004/